Commentary on Barré et al. (2020): Identifying remaining barriers to hepatitis C treatment in the DAA era
Gespeichert in:
| Veröffentlicht in: | Addiction (Abingdon, England) England), 2020-03, Vol.115 (3), p.583-584 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 584 |
|---|---|
| container_issue | 3 |
| container_start_page | 583 |
| container_title | Addiction (Abingdon, England) |
| container_volume | 115 |
| creator | Sacks‐Davis, Rachel Santen, Daniela K. Doyle, Joseph S. |
| description | |
| doi_str_mv | 10.1111/add.14887 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2331436520</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2331436520</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3837-7f24bb83a9b91d8c7711c43af1548a3791f8a8aa4fb58652578f3674082ec0d33</originalsourceid><addsrcrecordid>eNp10btOwzAUBmALgWgpDLwAssTSDmnt2LEdtpByqVSJBebISRzqKpdiO0J9JJ6DF8OlhQEJL_bwnV_W-QG4xGiK_ZnJspxiKgQ_AkNMGAoQpeQYDFHMoiDEFA3AmbVrhBAXMT0FA4KFiDBmQ7BOu6ZRrZNmC7sW3kpjPj-gclDWUzgOUYgmN3BReqGrrW5foVGN1O3ulXurlbHQdXClNtJppy1MoTNKul0m1C10KwXnSQKVkefgpJK1VReHewRe7u-e08dg-fSwSJNlUBBBeMCrkOa5IDLOY1yKgnOMC0pkhSMqJOExroQUUtIqjwSLwoiLijBOkQhVgUpCRmC8z92Y7q1X1mWNtoWqa9mqrrdZSAimxE8iT6__0HXXm9b_zqsojBljQng12avCdNYaVWUboxu_sQyjbFdA5gvIvgvw9uqQ2OeNKn_lz8Y9mO3Bu67V9v-kLJnP95Ffn0uMcw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2352966688</pqid></control><display><type>article</type><title>Commentary on Barré et al. (2020): Identifying remaining barriers to hepatitis C treatment in the DAA era</title><source>Wiley Online Library - AutoHoldings Journals</source><source>MEDLINE</source><creator>Sacks‐Davis, Rachel ; Santen, Daniela K. ; Doyle, Joseph S.</creator><creatorcontrib>Sacks‐Davis, Rachel ; Santen, Daniela K. ; Doyle, Joseph S.</creatorcontrib><identifier>ISSN: 0965-2140</identifier><identifier>EISSN: 1360-0443</identifier><identifier>DOI: 10.1111/add.14887</identifier><identifier>PMID: 31885116</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>Alcohol ; Alcohol use ; Alcoholism ; Antiviral Agents ; Antiviral drugs ; barriers to care ; direct‐acting antivirals ; Drug addiction ; Drug therapy ; France ; Hepatitis ; Hepatitis C ; Hepatitis C, Chronic ; Humans ; linkage to care ; people who inject drugs ; PWID ; Substance Abuse, Intravenous ; treatment ; treatment uptake</subject><ispartof>Addiction (Abingdon, England), 2020-03, Vol.115 (3), p.583-584</ispartof><rights>2019 Society for the Study of Addiction</rights><rights>2020 Society for the Study of Addiction</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3837-7f24bb83a9b91d8c7711c43af1548a3791f8a8aa4fb58652578f3674082ec0d33</cites><orcidid>0000-0003-0860-2762</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fadd.14887$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fadd.14887$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31885116$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sacks‐Davis, Rachel</creatorcontrib><creatorcontrib>Santen, Daniela K.</creatorcontrib><creatorcontrib>Doyle, Joseph S.</creatorcontrib><title>Commentary on Barré et al. (2020): Identifying remaining barriers to hepatitis C treatment in the DAA era</title><title>Addiction (Abingdon, England)</title><addtitle>Addiction</addtitle><subject>Alcohol</subject><subject>Alcohol use</subject><subject>Alcoholism</subject><subject>Antiviral Agents</subject><subject>Antiviral drugs</subject><subject>barriers to care</subject><subject>direct‐acting antivirals</subject><subject>Drug addiction</subject><subject>Drug therapy</subject><subject>France</subject><subject>Hepatitis</subject><subject>Hepatitis C</subject><subject>Hepatitis C, Chronic</subject><subject>Humans</subject><subject>linkage to care</subject><subject>people who inject drugs</subject><subject>PWID</subject><subject>Substance Abuse, Intravenous</subject><subject>treatment</subject><subject>treatment uptake</subject><issn>0965-2140</issn><issn>1360-0443</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp10btOwzAUBmALgWgpDLwAssTSDmnt2LEdtpByqVSJBebISRzqKpdiO0J9JJ6DF8OlhQEJL_bwnV_W-QG4xGiK_ZnJspxiKgQ_AkNMGAoQpeQYDFHMoiDEFA3AmbVrhBAXMT0FA4KFiDBmQ7BOu6ZRrZNmC7sW3kpjPj-gclDWUzgOUYgmN3BReqGrrW5foVGN1O3ulXurlbHQdXClNtJppy1MoTNKul0m1C10KwXnSQKVkefgpJK1VReHewRe7u-e08dg-fSwSJNlUBBBeMCrkOa5IDLOY1yKgnOMC0pkhSMqJOExroQUUtIqjwSLwoiLijBOkQhVgUpCRmC8z92Y7q1X1mWNtoWqa9mqrrdZSAimxE8iT6__0HXXm9b_zqsojBljQng12avCdNYaVWUboxu_sQyjbFdA5gvIvgvw9uqQ2OeNKn_lz8Y9mO3Bu67V9v-kLJnP95Ffn0uMcw</recordid><startdate>202003</startdate><enddate>202003</enddate><creator>Sacks‐Davis, Rachel</creator><creator>Santen, Daniela K.</creator><creator>Doyle, Joseph S.</creator><general>Blackwell Publishing Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7TK</scope><scope>8BJ</scope><scope>FQK</scope><scope>JBE</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-0860-2762</orcidid></search><sort><creationdate>202003</creationdate><title>Commentary on Barré et al. (2020): Identifying remaining barriers to hepatitis C treatment in the DAA era</title><author>Sacks‐Davis, Rachel ; Santen, Daniela K. ; Doyle, Joseph S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3837-7f24bb83a9b91d8c7711c43af1548a3791f8a8aa4fb58652578f3674082ec0d33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Alcohol</topic><topic>Alcohol use</topic><topic>Alcoholism</topic><topic>Antiviral Agents</topic><topic>Antiviral drugs</topic><topic>barriers to care</topic><topic>direct‐acting antivirals</topic><topic>Drug addiction</topic><topic>Drug therapy</topic><topic>France</topic><topic>Hepatitis</topic><topic>Hepatitis C</topic><topic>Hepatitis C, Chronic</topic><topic>Humans</topic><topic>linkage to care</topic><topic>people who inject drugs</topic><topic>PWID</topic><topic>Substance Abuse, Intravenous</topic><topic>treatment</topic><topic>treatment uptake</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sacks‐Davis, Rachel</creatorcontrib><creatorcontrib>Santen, Daniela K.</creatorcontrib><creatorcontrib>Doyle, Joseph S.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>International Bibliography of the Social Sciences (IBSS)</collection><collection>International Bibliography of the Social Sciences</collection><collection>International Bibliography of the Social Sciences</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Addiction (Abingdon, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sacks‐Davis, Rachel</au><au>Santen, Daniela K.</au><au>Doyle, Joseph S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Commentary on Barré et al. (2020): Identifying remaining barriers to hepatitis C treatment in the DAA era</atitle><jtitle>Addiction (Abingdon, England)</jtitle><addtitle>Addiction</addtitle><date>2020-03</date><risdate>2020</risdate><volume>115</volume><issue>3</issue><spage>583</spage><epage>584</epage><pages>583-584</pages><issn>0965-2140</issn><eissn>1360-0443</eissn><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>31885116</pmid><doi>10.1111/add.14887</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0003-0860-2762</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0965-2140 |
| ispartof | Addiction (Abingdon, England), 2020-03, Vol.115 (3), p.583-584 |
| issn | 0965-2140 1360-0443 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2331436520 |
| source | Wiley Online Library - AutoHoldings Journals; MEDLINE |
| subjects | Alcohol Alcohol use Alcoholism Antiviral Agents Antiviral drugs barriers to care direct‐acting antivirals Drug addiction Drug therapy France Hepatitis Hepatitis C Hepatitis C, Chronic Humans linkage to care people who inject drugs PWID Substance Abuse, Intravenous treatment treatment uptake |
| title | Commentary on Barré et al. (2020): Identifying remaining barriers to hepatitis C treatment in the DAA era |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T23%3A16%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Commentary%20on%20Barr%C3%A9%20et%20al.%20(2020):%20Identifying%20remaining%20barriers%20to%20hepatitis%20C%20treatment%20in%20the%20DAA%20era&rft.jtitle=Addiction%20(Abingdon,%20England)&rft.au=Sacks%E2%80%90Davis,%20Rachel&rft.date=2020-03&rft.volume=115&rft.issue=3&rft.spage=583&rft.epage=584&rft.pages=583-584&rft.issn=0965-2140&rft.eissn=1360-0443&rft_id=info:doi/10.1111/add.14887&rft_dat=%3Cproquest_cross%3E2331436520%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2352966688&rft_id=info:pmid/31885116&rfr_iscdi=true |